Financials Crossject

Equities

ALCJ

FR0011716265

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:35:21 2024-04-26 am EDT 5-day change 1st Jan Change
2.02 EUR +0.50% Intraday chart for Crossject -1.94% -59.36%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 18.2 46.16 77.73 78.44 99.04 76.81 76.81 -
Enterprise Value (EV) 1 19.86 46.7 77.73 88.99 105.4 189 104.6 91.21
P/E ratio -1.53 x -6.48 x -7.48 x -6.95 x -11 x -3.54 x -5.05 x 3.88 x
Yield - - - - - - - -
Capitalization / Revenue 5.16 x 7.7 x 13.6 x 86 x 104 x 14.7 x 20.8 x 1.59 x
EV / Revenue 5.63 x 7.79 x 13.6 x 97.6 x 110 x 14.7 x 28.3 x 1.89 x
EV / EBITDA -2.41 x -9.64 x -12.7 x -12.1 x -15.2 x -30.9 x -7.02 x 3.22 x
EV / FCF -1.76 x - - - - -5.8 x -7.64 x 6.81 x
FCF Yield -56.9% - - - - -17.2% -13.1% 14.7%
Price to Book - 15.4 x -64.3 x -13.4 x 44.6 x -4.04 x -3.61 x -50.5 x
Nbr of stocks (in thousands) 15,091 20,072 25,361 27,523 30,057 38,026 38,026 -
Reference price 2 1.206 2.300 3.065 2.850 3.295 2.020 2.020 2.020
Announcement Date 3/13/19 3/26/20 3/30/21 3/24/22 3/20/23 4/2/24 - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 3.524 5.994 5.731 0.912 0.954 12.83 3.7 48.3
EBITDA 1 -8.232 -4.846 -6.116 -7.333 -6.93 -6.115 -14.9 28.3
EBIT 1 -11.56 -8.643 -10.67 -11.82 -13.29 -12.3 -15 25.9
Operating Margin -327.92% -144.19% -186.22% -1,296.38% -1,392.87% -95.9% -405.41% 53.62%
Earnings before Tax (EBT) 1 -12.3 -8.533 -10.92 -12.52 -13.38 -11.33 - -
Net income 1 -10.71 - - - - -8.467 -15 19.4
Net margin -303.94% - - - - -66.01% -405.41% 40.17%
EPS 2 -0.7900 -0.3551 -0.4100 -0.4100 -0.3000 -0.5700 -0.4000 0.5200
Free Cash Flow 1 -11.29 - - - - -17.7 -13.7 13.4
FCF margin -320.37% - - - - -931.58% -370.27% 27.74%
FCF Conversion (EBITDA) - - - - - - - 47.35%
FCF Conversion (Net income) - - - - - - - 69.07%
Dividend per Share - - - - - - - -
Announcement Date 3/13/19 3/26/20 3/30/21 3/24/22 3/20/23 4/2/24 - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 1.66 0.54 - 10.5 6.36 25.8 27.8 14.4
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) -0.2012 x -0.1108 x - -1.439 x -0.9172 x -1.623 x -1.866 x 0.5088 x
Free Cash Flow 1 -11.3 - - - - -17.7 -13.7 13.4
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - 0.1500 -0.0500 -0.2100 0.0700 -0.5000 -0.5600 -0.0400
Cash Flow per Share -0.8300 -0.2700 -0.2300 -0.2300 -0.1400 - - -
Capex 1 3.27 - - - - 0.1 0.1 1.9
Capex / Sales 92.88% - - - - 5.26% 2.7% 3.93%
Announcement Date 3/13/19 3/26/20 3/30/21 3/24/22 3/20/23 4/2/24 - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.02 EUR
Average target price
5 EUR
Spread / Average Target
+147.52%
Consensus

Annual profits - Rate of surprise